What are the major opportunities in the Priorix market? What are the strategies for the Priorix market?

For detailed insights on the major opportunities and strategies in the Priorix market, Read More

How does the Priorix market relate to the overall economy and other similar markets?

For detailed insights on Priorix's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Priorix industry?

For detailed insights on the mergers and acquisitions in the Priorix industry, Read More

What are the key dynamics influencing the Priorix market growth? SWOT analysis of the Priorix market.

For detailed insights on the key dynamics influencing the Priorix market growth and SWOT analysis of the Priorix industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Priorix Global Market Report 2025

Name: Priorix Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Formulation (Lyophilized (Freeze-dried), Liquid), By Indication (Measles, Mumps, Rubella), By Age Group (Infants (0-12 months), Children (1-5 years)), By End Users (Pediatric Patients, Healthcare Providers)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Priorix Market?

Priorix is a combination vaccine used to protect against three infectious diseases namely measles, mumps, and Rubella (MMR). It contains live, attenuated viruses of these diseases, which stimulate the immune system to provide immunity. Typically administered as a subcutaneous or intramuscular injection, Priorix is given in two doses, the first at 12–15 months of age and the second around 4–6 years, depending on national immunization schedules.

The main formulations of priorix are lyophilized (freeze-dried) and liquid. Lyophilized vaccines are freeze-dried formulations designed to maintain stability and extend shelf life under specific conditions. The indications are measles, mumps, and rubella, and the age group includes infants (0-12 months) and children (1-5 years). It is used by various end users, such as pediatric patients and healthcare providers.

Priorix Market Size and growth rate 2025 to 2029: Graph

What Is The Priorix Market Size 2025 And Growth Rate?

The priorix market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the inclusion of priorix in the national immunization schedule, recurrent outbreaks of diseases, focus on combination vaccines, growing demand for cost-effective vaccines, and high efficacy of priorix.

What Is The Priorix Market Growth Forecast?

The priorix market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising adoption of WHO recommendations on immunization, rising school-based vaccination, expansion of retail pharmacy-based immunization services, focus on regional manufacturing, and increase in international funding. Major trends in the forecast period include partnerships for vaccine distribution, AI-based surveillance on immunization gaps, a shift towards decentralized vaccine manufacturing, the use of digital tools for vaccination tracking, and the development of temperature-stable vaccine formulation.

Book your 30 minutes free consultation with our research experts

How Is The Priorix Market Segmented?

The priorix market covered in this report is segmented –

1) By Formulation: Lyophilized (Freeze-dried); Liquid

2) By Indication: Measles; Mumps; Rubella

3) By Age Group: Infants (0-12 months); Children (1-5 years)

4) By End Users: Pediatric Patients; Healthcare Providers

What Is Driving The Priorix Market? Rising Prevalence Of Mumps Fuels Market Growth

The rise in the prevalence of mumps is expected to propel the priorix market going forward. Mumps is a contagious viral infection characterized by painful swelling of the salivary glands, particularly the parotid glands, located below the ears. The rise in mumps prevalence is driven by waning immunity from childhood vaccinations, insufficient vaccine coverage, and increased outbreaks in crowded settings such as schools and colleges. Priorix is used to prevent mumps by providing active immunization against the mumps virus as part of a combination vaccine. It stimulates the immune system to produce antibodies, reducing infection risk and curbing outbreaks. For instance, in December 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the total number of mumps cases in the US in 2022 was 386, which reached 436 in 2023. Therefore, the rise in the prevalence of mumps drives the priorix market.

What Is Driving The Priorix Market? Rising Healthcare Expenditure Fuels Market Growth

The rise in healthcare expenditure is expected to propel the priorix market going forward. Healthcare expenditure refers to the total amount of financial resources spent on medical services, healthcare infrastructure, pharmaceuticals, and healthcare-related activities. Healthcare expenditure is rising due to factors such as higher operational costs in healthcare facilities, increasing prevalence of chronic and lifestyle-related diseases, rise in prevalence of genetic disorders, advances in medical technology, and greater access to healthcare services. Increasing healthcare expenditure supports the widespread use of priorix by improving access to vaccination programs and helping prevent measles, mumps, and rubella in vulnerable populations. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the increase in healthcare expenditure drives the priorix market.

Who Are The Major Players In The Global Priorix Market?

Major companies operating in the priorix market are GSK plc

What Are The Key Trends Of The Global Priorix Market? FDA Approval Of Priorix Enhances Measles Mumps And Rubella Vaccination Options

The key trend in the priorix market is the regulatory approval of priorix for preventing measles, mumps, and rubella. This approval offers an additional vaccination option against these highly contagious diseases, which remain significant global health threats. For instance, in June 2022, GSK plc, a UK-based pharmaceutical and biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has approved Priorix, a live vaccine for the prevention of measles, mumps, and rubella (MMR) in individuals aged 12 months and older. Priorix is administered as a two-dose series, with the first dose given between 12 to 15 months of age and the second dose at 4 to 6 years of age. It can also be used as a second dose for individuals who have received the first dose of another MMR vaccine.

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Priorix Market

North America was the largest region in the priorix market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the priorix market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the priorix market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Priorix Market?

The priorix market consists of sales of pre-filled vials, diluents, and delivery kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Priorix Industry?

The priorix market research report is one of a series of new reports from The Business Research Company that provides priorix market statistics, including priorix industry global market size, regional shares, competitors with a priorix market share, detailed priorix market segments, market trends and opportunities, and any further data you may need to thrive in the priorix industry. This priorix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Priorix Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The priorix market covered in this report is segmented – 1) By Formulation: Lyophilized (Freeze-dried); Liquid 2) By Indication: Measles; Mumps; Rubella 3) By Age Group: Infants (0-12 months); Children (1-5 years) 4) By End Users: Pediatric Patients; Healthcare Providers
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	GSK plc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Priorix Market Characteristics

3. Priorix Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Priorix Market Trends And Strategies

5. Priorix Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Priorix Growth Analysis And Strategic Analysis Framework

6.1. Global Priorix PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Priorix Market Growth Rate Analysis

6.4. Global Priorix Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Priorix Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Priorix Total Addressable Market (TAM)

7. Global Priorix Pricing Analysis & Forecasts

8. Priorix Market Segmentation

8.1. Global Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Lyophilized (Freeze-dried)

Liquid

8.2. Global Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Measles

Mumps

Rubella

8.3. Global Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Infants (0-12 months)

Children (1-5 years)

8.4. Global Priorix Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Pediatric Patients

Healthcare Providers

9. Global Priorix Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Priorix Market Regional And Country Analysis

10.1. Global Priorix Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Priorix Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Priorix Market

11.1. Asia-Pacific Priorix Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Priorix Market

12.1. China Priorix Market Overview

12.2. China Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Priorix Market

13.1. India Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Priorix Market

14.1. Japan Priorix Market Overview

14.2. Japan Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Priorix Market

15.1. Australia Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Priorix Market

16.1. South Korea Priorix Market Overview

16.2. South Korea Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Priorix Market

17.1. Western Europe Priorix Market Overview

17.2. Western Europe Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Priorix Market

18.1. UK Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Priorix Market

19.1. Germany Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Priorix Market

20.1. France Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Priorix Market

21.1. Eastern Europe Priorix Market Overview

21.2. Eastern Europe Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Priorix Market

22.1. North America Priorix Market Overview

22.2. North America Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Priorix Market

23.1. USA Priorix Market Overview

23.2. USA Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Priorix Market

24.1. Canada Priorix Market Overview

24.2. Canada Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Priorix Market

25.1. South America Priorix Market Overview

25.2. South America Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Priorix Market

26.1. Middle East Priorix Market Overview

26.2. Middle East Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Priorix Market

27.1. Africa Priorix Market Overview

27.2. Africa Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Priorix Market Competitive Landscape And Company Profiles

28.1. Priorix Market Competitive Landscape

28.2. Priorix Market Company Profiles

28.2.1. GSK plc Overview, Products and Services, Strategy and Financial Analysis

28.2.2. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.3. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.4. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.5. 0 Overview, Products and Services, Strategy and Financial Analysis

29. Global Priorix Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Priorix Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Priorix Market

32. Recent Developments In The Priorix Market

33. Priorix Market High Potential Countries, Segments and Strategies

33.1 Priorix Market In 2029 - Countries Offering Most New Opportunities

33.2 Priorix Market In 2029 - Segments Offering Most New Opportunities

33.3 Priorix Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Priorix Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Priorix Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Priorix Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: GSK plc Financial Performance

Table 61: 0 Financial Performance

Table 62: 0 Financial Performance

Table 63: 0 Financial Performance

Table 64: 0 Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Priorix Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Priorix Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Priorix Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Priorix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Priorix Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Priorix Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: GSK plc Financial Performance

Figure 61: 0 Financial Performance

Figure 62: 0 Financial Performance

Figure 63: 0 Financial Performance

Figure 64: 0 Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Adult Vaccines Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vac...

Porcine Vaccine Global Market Report 2025 – By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines), By Disease Indication (Diarrhea, Swine ...

Typhoid Vi Polysaccharide Vaccine Global Market Report 2025 – By Type( Child, Adult ), By Route of Administration( Oral, Parenteral ), By Application( Government Institution, Private Sector, Other Applications ) – Impact...

Dog Vaccines Global Market Report 2025 – By Type( Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), By Route Of Administration( Su...

Foot And Mouth Disease Vaccine Global Market Report 2025 – By Vaccine Type( Conventional Vaccines, Oil Based Vaccines, Aluminum Hydroxide/Saponin Based Vaccines, Emergency Vaccines), By Animal Type( Cattle, Pig, Sheep an...

Chickenpox Vaccine Global Market Report 2025 – By Vaccine (Monovalent varicella vaccine, Combination varicella vaccine), By Application (Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immunization, Ch...

Poultry Vaccines Global Market Report 2025 – By Type (Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines), By Disease Type (Avain Influenza, Infect...

Frequently Asked Questions

What is the definition of the Priorix market?

Priorix is a combination vaccine used to protect against three infectious diseases namely measles, mumps, and rubella (MMR). It contains live, attenuated viruses of these diseases, which stimulate the immune system to provide immunity. Typically administered as a subcutaneous or intramuscular injection, Priorix is given in two doses, the first at 12–15 months of age and the second around 4–6 years, depending on national immunization schedules. For further insights on the Priorix market, request a sample here

How will the Priorix market drivers and restraints affect the market dynamics? What forces will shape the Priorix industry going forward?

The Priorix market major growth driver - Rising Prevalence Of Mumps Fuels Market Growth. For further insights on the Priorix market, request a sample here

What is the forecast market size or the forecast market value of the Priorix market?

The Priorix market size has grown strongly in recent years. The priorix market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the inclusion of priorix in the national immunization schedule, recurrent outbreaks of diseases, focus on combination vaccines, growing demand for cost-effective vaccines, and high efficacy of priorix. The priorix market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising adoption of WHO recommendations on immunization, rising school-based vaccination, expansion of retail pharmacy-based immunization services, focus on regional manufacturing, and increase in international funding. Major trends in the forecast period include partnerships for vaccine distribution, AI-based surveillance on immunization gaps, a shift towards decentralized vaccine manufacturing, the use of digital tools for vaccination tracking, and the development of temperature-stable vaccine formulation. For further insights on the Priorix market, request a sample here

How is the Priorix market segmented?

The priorix market covered in this report is segmented –
1) By Formulation: Lyophilized (Freeze-dried); Liquid
2) By Indication: Measles; Mumps; Rubella
3) By Age Group: Infants (0-12 months); Children (1-5 years)
4) By End Users: Pediatric Patients; Healthcare Providers For further insights on the Priorix market, request a sample here

Which region has the largest share of the Priorix market? What are the other regions covered in the report?

Who are the major players in the Priorix market?

Major companies operating in the priorix market are GSK plc . For further insights on the Priorix market, request a sample here.

What are the key trends in the Priorix market?

Major trends in the Priorix market include FDA Approval Of Priorix Enhances Measles Mumps And Rubella Vaccination Options. For further insights on the Priorix market, request a sample here.